US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 0.674
  • -0.086-11.37%
Close Dec 13 16:00 ET
  • 0.700
  • +0.026+3.86%
Post 20:01 ET
196.86MMarket Cap-0.85P/E (TTM)

About Lyell Immunopharma Company

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Company Profile

SymbolLYEL
Company NameLyell Immunopharma
Listing DateJun 17, 2021
Issue Price17.00
Founded2018
CEODr. Lynn Seely,M.D.
MarketNASDAQ
Employees224
Fiscal Year Ends12-31
Address201 Haskins Way
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-695-0677
Websitehttp://www.lyell.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lynn Seely,M.D.
  • Director, President and Chief Executive Officer
  • 2.65M
  • Charles Newton
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Matthew Lang
  • Chief Business Officer
  • 4.01M
  • Dr. Gary Lee, PhD
  • Chief Scientific Officer
  • 2.23M
  • Stephen Hill
  • Chief Operating Officer
  • 3.11M
  • Richard D. Klausner
  • Chairman of the Board
  • 310.75K
  • Dr. Sumant Ramachandra,M.D.,PhD
  • Director
  • --
  • Robert Taylor Nelsen
  • Independent Director
  • 286.75K
  • William J. Rieflin
  • Independent Director
  • 301.75K
  • Catherine J. Friedman
  • Lead Independent Director
  • 330.25K
  • Dr. Otis W. Brawley,M.D.
  • Independent Director
  • 290.75K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 293.25K
Heat List
US
Overall
Symbol
Price
% Chg

No Data